These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 20597611)
1. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Womens Health (Lond); 2010 Jul; 6(4):493. PubMed ID: 20597611 [No Abstract] [Full Text] [Related]
2. Denosumab: new horizons in the treatment of osteoporosis. Wilton JM Nurs Womens Health; 2011; 15(3):249-52. PubMed ID: 21672176 [No Abstract] [Full Text] [Related]
3. Denosumab, osteoporosis, and prevention of fractures. Blythe SL N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410 [No Abstract] [Full Text] [Related]
4. Denosumab, osteoporosis, and prevention of fractures. Blackwood J N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411 [No Abstract] [Full Text] [Related]
5. Denosumab, osteoporosis, and prevention of fractures. Kyrgidis A N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950409 [No Abstract] [Full Text] [Related]
6. Denosumab (prolia) for postmenopausal osteoporosis. Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756 [No Abstract] [Full Text] [Related]
7. New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol. Hussar DA; Stevenson T J Am Pharm Assoc (2003); 2010; 50(5):658-62. PubMed ID: 20833626 [No Abstract] [Full Text] [Related]
8. Denosumab, osteoporosis, and prevention of fractures. Kiechl S; Willeit J; Schett G N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304 [No Abstract] [Full Text] [Related]
9. [Denosumab efficient against osteoporosis. A biological drug gives new possibilities to treat a public disease]. Törring O Lakartidningen; 2010 Mar 3-9; 107(9):574-5. PubMed ID: 20387753 [No Abstract] [Full Text] [Related]
11. [Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis]. Bruhn C Med Monatsschr Pharm; 2010 Oct; 33(10):370-5. PubMed ID: 21072910 [TBL] [Abstract][Full Text] [Related]
12. [Denosumab for treatment of postmenopausal osteoporosis]. Syversen U; Halse JI; Geisler J; Eriksen EF Tidsskr Nor Laegeforen; 2011 Oct; 131(19):1893-6. PubMed ID: 21984295 [TBL] [Abstract][Full Text] [Related]
18. Clinical use of denosumab for the treatment for postmenopausal osteoporosis. Lewiecki EM Curr Med Res Opin; 2010 Dec; 26(12):2807-12. PubMed ID: 21050058 [TBL] [Abstract][Full Text] [Related]
19. Denosumab in osteoporosis and oncology. Burkiewicz JS; Scarpace SL; Bruce SP Ann Pharmacother; 2009 Sep; 43(9):1445-55. PubMed ID: 19622756 [TBL] [Abstract][Full Text] [Related]
20. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data. Dempster DW; Lambing CL; Kostenuik PJ; Grauer A Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]